CNBS ETF — Amplify Seymour Cannabis ETF

Amplify Seymour Cannabis ETF (CNBS)

Updated October 16, 2026.

CNBS is an ETF. its expense ratio is 0.76%. Total return is -88.5% over the past 7.2 years, 271.0 points behind SPY at 182.5%.

Amplify Seymour Cannabis ETF is an ETF that tracks U.S. companies engaged in cannabis and hemp-related activities, investing at least 80% of its assets in companies deriving half or more of their revenue from the cannabis and hemp ecosystem. The fund does not currently distribute income to shareholders, though it has made special distributions in the past that may not recur regularly. It carries an expense ratio of 0.76% and appeals primarily to investors seeking exposure to the cannabis sector rather than income-focused investors.

CNBS performance versus SPY

Price and return data through 2026-10-16.

Total return is -88.5% over the past 7.2 years, 271.0 points behind SPY at 182.5%. Over the past year its total return — price change plus distributions reinvested — is -26.3%. Its deepest 1-year drawdown was 51.3%.

CNBS key facts

Issuer

Amplify ETFs

Asset type

ETF

Asset class

Equity

Inception date

07/15/2019

Expense ratio

0.76%

Distribution frequency

None

Last close

$22.75 (as of 2026-10-16)

AUM

$65,082,373

Average volume

4654.0

Ex-dividend date

12/30/2024

Payment date

12/31/2024

Beta

1.3

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: Amplify ETFs or company page; prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

CNBS risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 51.3%.

Who may consider CNBS — and who may not

It is a weaker fit for investors who need monthly cash flow (CNBS does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on CNBS

• All tickers starting with C

Tagged: Cannabis.

Frequently asked questions

More securities from Amplify ETFs.